Phase 1 Clinical Trials: Challenges and Opportunities in Latin America by Mirella Nardo, Camila Bragança Xavier, Fabio Franke

Get full text

A Comprehensive Exploration of Agents Targeting Tumor Microenvironment: Challenges and Future Perspectives by Carlos Diego Holanda Lopes, Camila Braganca Xavier, Carlos Torrado, Ana Carolina Veneziani, Thais Baccili Cury Megid

Get full text

Cardiovascular toxicity following immune checkpoint inhibitors: A systematic review and meta-analysis by Camila Bragança Xavier, Carlos Diego Holanda Lopes, Guilherme Harada, Eduardo Dante Bariani Peres, Artur Katz, Denis Leonardo Jardim

Get full text

CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report by Aline Cristini Vieira, Camila Bragança Xavier, Thiago Dieb Vieira, Filomena Marino Carvalho, Mariana Scaranti, Rodrigo Ramela Munhoz, Jesus Paula Carvalho

Get full text

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report by Luciana Beatriz Mendes Gomes, Renata Lazari Sandoval, Camila Bragança Xavier, Tatiana Strava Correa, Raquel Midori Koga Matuda, Zenaide Silva de Souza, Luiz Guilherme Cernaglia Aureliano de Lima, Mariana Petaccia de Macedo, Filomena Marino Carvalho, Daniele Assad Suzuki

Get full text

The addition of PD-1/PD-L1 axis blockade to BRAF and MEK inhibition for advanced melanoma patients harboring BRAF mutations: a systematic review and meta-analysis by Mauricio Fernando Silva Almeida Ribeiro, Camila Bragança Xavier, Allan Andresson Lima Pereira, Mariana Scaranti, Luiza Dib Batista Bugiato Faria, Tatiana Strava Correa, Marina Sahade, David Queiroz Borges Muniz, Olavo Feher, Gustavo dos Santos Fernandes, Artur Katz, Rodrigo Ramella Munhoz

Get full text